IMPT Dose Escalation for NSCLC (HyDose)

NCT06484491 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

RADIATION: Dose-escalated intensity-modulated proton therapy (IMPT-74)
DRUG: Cisplatin or carboplatin + pemetrexed for induction chemotherapy, cisplatin + docetaxel for concurrent chemotherapy
DRUG: Immunotherapy: adjuvant durvalumab

Sponsor

University Medical Center Groningen